Total Funding
2
22
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
537378
Hansen Pharmaceutical offers a technology that delivers gaseous nitric oxide under pressure to kill multi-drug resistant organisms.
- Jason Hanft: Co-Founder and President
- Jeffrey Jensen: Co-Founder
About the Company
Hansen Pharmaceutical offers proprietary technology that delivers gaseous nitric oxide under pressure to kill multi-drug resistant organisms.
Since spinning out the technology and intellectual property in 2017, Hansen is building on the groundbreaking work started at Barry University’s Paul & Margaret Brand Research Center at the School of
Podiatric Medicine.
